Panacea Life Sciences Holdings, Inc. (PLSH)

0.1384 0.0000 (0.00%) At close: 03:19PM EDT

Panacea Life Sciences Holdings, Inc.

5910 South University Boulevard
C18-193
Greenwood Village, CO 80121
United States
800-985-0515
https://www.panacealife.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 40

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Leslie A. Buttorff	Chairman, CEO & CFO	N/A	N/A	1958
Mr. Nicholas J. Cavarra	President, Senior Vice President of Marketing & Sales	N/A	N/A	1966
Mr. Nathan Joel Berman	Secretary, Controller & Principal Accounting Officer	N/A	N/A	1988
Dr. James W. Baumgartner Ph.D.	Chief Science Officer & Quality Control	N/A	N/A	1966

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Panacea Life Sciences Holdings, Inc., operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other hemp companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies under the PANA Health, PANA Beauty, PANA Pet, PANA Sport, PANA Pure, and PANA Life brand name. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.

Corporate governance

Panacea Life Sciences Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.